Atinumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | RTN4 |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| CAS Number |
1226761-65-4  |
| ChemSpider | none |
| UNII |
9UBQ62RW32  |
| (what is this?) (verify) | |
Atinumab is an immunomodulator. It binds to reticulon 4.[1]
References
- ↑ World Health Organization (2010). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 104" (PDF). WHO Drug Information. 24 (4).
This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.